期刊文献+

PCA3联合mMRI在前列腺癌诊断中的意义 被引量:2

The significance of PCA3 combining with mMRI in detecting of prostate cancer
下载PDF
导出
摘要 目的探讨前列腺癌基因3(prostate cancer gene 3,PCA3)和多参数磁共振成像(multiparametric magnetic resonance imaging,mMRI)对前列腺癌的诊断意义。方法对56例首次穿刺结果为阴性但PSA持续升高的患者在第二次穿刺活检之前行PCA3和mMRI检查。评估PCA3评分和mMRI对前列腺癌诊断的准确性和可靠度及其对前列腺穿刺结果的预测性。结果 mMRI结果显示20例(35.7%)患者具有前列腺癌特征;PCA3评分(截断值为35时)显示15例(26.8%)患者疑为前列腺癌;前列腺穿刺活检结果显示23例(41.1%)患者确诊为前列腺癌。PCA3和mMRI对前列腺癌诊断的敏感性和特异性分别为67%、49%及74%、89%。结论 mMRI增加了PCA3对前列腺癌诊断的准确性和敏感性,可以减少不必要的前列腺穿刺。 Objective To evaluate the value of the urinary prostate cancer gene 3(PCA3)assay combining multiparametric magnetic resonance imaging(mMRI)in diagnosis of prostate cancer(PCa). Methods A study of 56 patients with a longlasting high prostate-specific antigen level and previously negative biopsy was performed to assess the role of mMRI and PCA3 in identifying PCa,the accuracy and reliability were evaluated. Results mMRI showed that 20(35.7%)patients were may sufferer PCa;And PCA3 scores showed that 15(26.8%)cases may suffer from PCa;Repeated transrectal ultrasound(TRUS)-guided biopsy identified 23(41.1%)new cases of PCa.The sensitivity and specificity of PCA3 test and mMRI was 67%and 49%and 74%and 89%,respectively.The study showed that the model included mMRI and PCA3 had a better performance in predicting PCa. Conclusions mMRI can improve the accuracy and sensitivity of PCA3 for diagnosis of PCa,therefore,can avoid unnecessary biopsies.
出处 《现代泌尿生殖肿瘤杂志》 2014年第4期224-227,共4页 Journal of Contemporary Urologic and Reproductive Oncology
关键词 前列腺肿瘤 PCA3 mMRI 肿瘤标记 生物学 Prostatic neoplasms PCA3 mMRI Tumor markers biological
  • 相关文献

参考文献18

  • 1Bary F, Lortet-Tieulent J, Ferlay J, et al. Prostate cancer incidence and mortality trends in 37 European countres:an o- verview[J]. Eur J Cancer, 2010,46 (17) : 3040-3052.
  • 2Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2011:the impact of eliminating socioeconomic and racial disparities on pre- mature cancer death[J]. CA Cancer J Clin,2011,61(4) :212-236.
  • 3Sciarra A, Autran Gomez A, Salciccia S, et al. Biopsy-de- rived Gleason artifact and prostate volume: experience using ten samples in larger prostates[J]. Urol Int, 2008, 80 (2) : 145-150.
  • 4Heidenreich A, Aus G, Bolla M, et al. EAU guidelines on pros- tate cancer[J]. Eur Urol, 2008,53 (1) : 68-80.
  • 5Sardana G, Dowell B, Diamandis EP. Emerging biomarkers for the diagnosis and prognosis of prostate cancer[J]. Clin Chem, 2008,54 (12) : 1951-1960.
  • 6Auprich M, Bjartell A, Chun F, et al. Contemporary role of prostate cancer antigen 3 in the management of prostate canc- er[J]. Eur Urol,2011,60(5) : 1045-1054.
  • 7Marks LS, Fradet Y, Deras IL, et al. PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy [J]. Urology, 2007,69 (3) : 532-535.
  • 8Ruiz-Aragon J, Marquez-Pelaez S. Assessment of the PCA3 test for prostate cancer diagnosis: a systematic review and recta-analysis[J]. Actas Urol Esp, 2010,34 (4) : 346-355.
  • 9Chun FK, Epstein JI, Ficarra V, et al. Optimizing perform- ance and interpretation of prostate biopsyz a critical analysis of the literature[J]. Eur Urol, 2010,58 (6) : 851-864.
  • 10Wang R, Chinnaiyan AM, Dunn RL, et al. Rational approach to implementation of prostate cancer antigen 3 into clinical care[J]. Cancer,2009,115(17) : 3879-3886.

同被引文献21

  • 1Kristen P. Nickens,Amina Ali,Tatiana Scoggin,Shyh‐Han Tan,Lakshmi Ravindranath,David G. McLeod,Albert Dobi,David Tacha,Isabell A. Sesterhenn,Shiv Srivastava,Gyorgy Petrovics.??Prostate cancer marker panel with single cell sensitivity in urine(J)Prostate . 2015 (9)
  • 2Cantiello F,Russo GI,Ferro M,et al.Prognostic accuracy of Prostate Health Index and urinary Prostate Cancer Antigen 3 in predicting pathologic features after radical prostatectomy. Urologic Oncology . 2015
  • 3De Luca S,Passera R,Bollito E,et al.Comparison of prostate cancer gene 3 score,prostate health index and percentage free prostate-specific antigen for differentiating histological inflammation from prostate cancer and other non-neoplastic alterations of the prostate at initial biopsy. Anticancer Research . 2014
  • 4Cheng HH,Soleau C,Yu EY.Improved disease markers suggest dual response in a patient with metastatic castration resistant prostate cancer and chronic lymphocytic leukemia following active cellular immunotherapy. J Hematol Oncol . 2015
  • 5Faruque MU,Paul R,Ricks-Santi L,et al.Analyzing the Association of Polymorphisms in the CRYBB2 Gene with Prostate Cancer Risk in African Americans. Anticancer Research . 2015
  • 6DE Luca S,Passera R,Cappia S,et al.Pathological patterns of prostate biopsy in men with fluctuations of prostate cancer gene 3 score:a preliminary report. Anticancer Research . 2015
  • 7Mostofi F K.Problems of grading carcinoma of prostate. Seminars in Oncology . 1976
  • 8朱圣生,刘向云,孙祖越.前列腺特异性抗原衍生体及前列腺癌高特异性生物标志研究现状[J].中国药理学与毒理学杂志,2013,27(1):114-118. 被引量:16
  • 9杨帮东,姜行康,齐灿,李海波,刘冉录,杨阔,乔宝民,张志宏,徐勇.尿液中PCA3评分对前列腺癌早期诊断的临床意义[J].天津医科大学学报,2013,19(6):487-489. 被引量:4
  • 10李辉明,魏世平,陶维雄,王进,彭伟,顾鹏.前列腺癌病理分级、临床分期和血清PSA的关系[J].中国临床研究,2014,27(1):37-38. 被引量:12

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部